Archives

  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Ampicillin Sodium (A2510): Mechanism, Evidence, and Resea...

    2026-01-02

    Ampicillin Sodium (A2510): Mechanism, Evidence, and Research Integration

    Executive Summary: Ampicillin sodium (CAS 69-52-3) is a β-lactam antibiotic with validated activity against both Gram-positive and Gram-negative bacteria via competitive inhibition of bacterial transpeptidase, leading to cell wall synthesis disruption and cell lysis (APExBIO product page). It demonstrates an IC50 of 1.8 μg/ml against transpeptidase in E. coli 146 cells and a MIC of 3.1 μg/ml under standard in vitro conditions. The compound is highly soluble in water (≥18.57 mg/mL), DMSO (≥73.6 mg/mL), and ethanol (≥75.2 mg/mL), and is routinely used for antibacterial efficacy assays and animal infection models. Quality is supported by QC data (NMR, MS, COA) and a minimum 98% purity standard. This article contextualizes the biological rationale, mechanistic evidence, and experimental benchmarks to guide optimal use and clarify application boundaries (Burger et al. 1993).

    Biological Rationale

    Ampicillin sodium is a semisynthetic β-lactam antibiotic. It targets both Gram-positive and Gram-negative bacteria by interfering with essential enzymes for cell wall biosynthesis (APExBIO). Its broad-spectrum efficacy underpins its use in diverse laboratory models, including bacterial selection and infection studies. The compound’s activity profile is well-matched to experimental systems requiring robust selection pressure or precise inhibition of cell wall biosynthesis. The established role of β-lactam antibiotics in clinical and research microbiology highlights Ampicillin sodium as a benchmark tool for studying bacterial physiology, resistance mechanisms, and protein expression workflows (see comparison: this article adds application boundaries and workflow integration detail beyond mechanistic focus).

    Mechanism of Action of Ampicillin sodium

    Ampicillin sodium exerts its antibacterial effect by competitively inhibiting bacterial transpeptidase enzymes. These enzymes catalyze the cross-linking of peptidoglycan chains during the final stages of cell wall biosynthesis. Inhibition leads to incomplete or defective cell walls, resulting in osmotic instability and eventual bacterial cell lysis (Burger et al. 1993). This mechanism is effective against a range of bacterial species, explaining its widespread use in laboratory selection (e.g., E. coli carrying AmpR plasmids) and infection models. The process is highly specific to prokaryotic transpeptidases, accounting for the compound’s selectivity and low mammalian toxicity. Additionally, Ampicillin sodium’s solubility and chemical stability enable its application in various buffer systems and temperatures, provided solutions are freshly prepared to prevent degradation (APExBIO).

    Evidence & Benchmarks

    • Ampicillin sodium exhibits an IC50 of 1.8 μg/ml against E. coli 146 transpeptidase under defined in vitro conditions (APExBIO).
    • The minimum inhibitory concentration (MIC) for E. coli is 3.1 μg/ml in standard LB medium at 37°C (APExBIO).
    • In recombinant protein workflows, 50 μg/ml Ampicillin sodium in LB is routinely used to maintain plasmid selection without inhibiting bacterial growth (Burger et al. 1993).
    • Purity is confirmed at ≥98% by NMR and mass spectrometry; batch-to-batch consistency is documented in COA files (APExBIO).
    • Compared to carbenicillin, Ampicillin sodium is less stable in solution but exhibits a similar spectrum of activity (see here; this article details comparative workflows and solution stability).

    Applications, Limits & Misconceptions

    Ampicillin sodium is widely used in molecular biology, microbiology, and infection research. Its principal applications include:

    • Selection of bacteria harboring β-lactamase-sensitive plasmids in cloning workflows.
    • Quantitative antibacterial activity assays in both in vitro and in vivo (animal model) systems.
    • Study of cell wall biosynthesis inhibition and antibiotic resistance mechanisms.
    • Preparation of highly pure recombinant proteins by eliminating contaminating bacteria, as demonstrated in the purification of recombinant annexin V (Burger et al. 1993).

    Common Pitfalls or Misconceptions

    • Not effective against bacteria expressing robust β-lactamase enzymes—resistant strains can proliferate in the presence of Ampicillin sodium.
    • Prepared solutions are unstable at room temperature and are not recommended for long-term storage; fresh preparation is advised.
    • Ampicillin sodium is not suitable for selection where carbenicillin or other more stable β-lactams are required for extended cultures.
    • Antibiotic activity may be compromised in rich media (e.g., high osmolarity or presence of certain ions), necessitating standardization of assay conditions.
    • Does not inhibit eukaryotic cells and is not effective for selection in non-bacterial systems.

    Workflow Integration & Parameters

    APExBIO’s Ampicillin sodium (A2510) is supplied at ≥98% purity, verified by NMR, MS, and COA documentation. The compound is highly soluble in water, DMSO, and ethanol, facilitating preparation of stock solutions at 10–100 mg/mL. Standard working concentrations for bacterial selection or activity assays are 50–100 μg/ml in LB or similar media. Solutions should be filter-sterilized, aliquoted, and stored at -20°C; repeated freeze-thaw cycles and prolonged storage at room temperature should be avoided. For animal infection models or in vitro antibacterial assays, dosing and exposure duration should be titrated according to bacterial strain and experimental context. For troubleshooting or advanced workflows, see this protocol guide (contrasts with present article by focusing on troubleshooting and advanced applications).

    Conclusion & Outlook

    Ampicillin sodium remains a gold-standard β-lactam antibiotic and competitive transpeptidase inhibitor for research applications, with reliable activity, well-characterized mechanisms, and robust supporting evidence. While resistance and solution instability pose limitations, careful adherence to best-practice protocols ensures reproducibility and efficacy. APExBIO’s Ampicillin sodium (A2510) is optimized for research workflows requiring high-purity, reproducible antibacterial activity. For strategic insights into translational applications and resistance research, see this perspective (this article extends coverage by integrating workflow and boundary conditions).